Pancreatic Cancer Research

ResearcherNewcastle upon Tyne Hospitals NHS Foundation TrustNo recent work listed

Derek Manas

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3066-4601; OpenAlex author ID A5068818049. Sources: OpenAlex.

Their work

Papers
8 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
20
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 3 papers · 2021: 2 papers · 2022: 1 paper

Papers 8

  1. Treatment of unresectable locally advanced pancreatic cancer with percutaneous irreversible electroporation (IRE) following initial systemic chemotherapy (LAP-… Co-author DOI 10.1136/bmjopen-2021-050166↗
  2. Margin Accentuation Irreversible Electroporation in Stage III Pancreatic Cancer: A Systematic Review. Co-author DOI 10.3390/cancers13133212↗
  3. Irreversible Electroporation (IRE) in Locally Advanced Pancreatic Cancer: A Review of Current Clinical Outcomes, Mechanism of Action and Opportunities for Syne… Co-author DOI 10.3390/jcm10081609↗
  4. A systematic review and network meta-analysis of phase III randomised controlled trials for adjuvant therapy following resection of pancreatic ductal adenocarc… Co-author DOI 10.1016/j.hpb.2019.12.001↗
  5. Prospective assessment of resection margin status following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma after standardisation of margin defini… Co-author DOI 10.1016/j.pan.2020.01.004↗
  6. Therapeutic Strategies Toward Lactate Dehydrogenase Within the Tumor Microenvironment of Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000001689↗
  7. Systematic review of irreversible electroporation in the treatment of advanced pancreatic cancer. Last author DOI 10.1016/j.ejso.2014.08.480↗
  8. Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.ejso.2011.12.020↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zainab L. Rai · 2 shared papers, 2021–2022 · strength 0.31
  2. Brian Ritchie Davidson · 2 shared papers, 2021–2022 · strength 0.31
  3. Steven Alan White · 3 shared papers, 2012–2020 · strength 0.29
  4. Beate Haugk · 3 shared papers, 2012–2020 · strength 0.25
  5. Stuart Michael Robinson · 3 shared papers, 2012–2020 · strength 0.25
  6. Richard Charnley · 3 shared papers, 2012–2020 · strength 0.25
  7. John A. G. Moir · 2 shared papers, 2014–2020 · strength 0.16
  8. Bathiya Ratnayake · 1 shared paper, 2021 · strength 0.15
  9. Sanjay Pandanaboyana · 1 shared paper, 2021 · strength 0.15
  10. Wasfi Alrawashdeh · 1 shared paper, 2020 · strength 0.15
  11. Sivesh Kathir Kamarajah · 1 shared paper, 2020 · strength 0.15
  12. James Bundred · 1 shared paper, 2020 · strength 0.15
  13. Nicola de Liguori Carino · 1 shared paper, 2022 · strength 0.13
  14. David Christopher Bartlett · 1 shared paper, 2022 · strength 0.13
  15. Kurinchi Selvan Gurusamy · 1 shared paper, 2022 · strength 0.13
  16. Paula Ghaneh · 1 shared paper, 2022 · strength 0.13
  17. Daniel H. Palmer · 1 shared paper, 2022 · strength 0.13
  18. Steve A. White · 1 shared paper, 2020 · strength 0.11
  19. James K. Pine · 1 shared paper, 2020 · strength 0.11
  20. Jelena Mann · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.